These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 17934879)
1. Current strategies for ischemic stroke prevention: role of multimodal combination therapies. Alberts MJ; Ovbiagele B J Neurol; 2007 Oct; 254(10):1414-26. PubMed ID: 17934879 [TBL] [Abstract][Full Text] [Related]
2. New perspectives on the pharmacotherapy of ischemic stroke. Bradberry JC; Fagan SC; Gray DR; Moon YS J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S46-56; quiz S56-7. PubMed ID: 15095935 [TBL] [Abstract][Full Text] [Related]
3. The emergency department: first line of defense in preventing secondary stroke. Ovbiagele B Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789 [TBL] [Abstract][Full Text] [Related]
4. Secondary stroke prevention: from guidelines to clinical practice. Graham GD J Natl Med Assoc; 2008 Oct; 100(10):1125-37. PubMed ID: 18942273 [TBL] [Abstract][Full Text] [Related]
5. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care. Pepine CJ Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398 [TBL] [Abstract][Full Text] [Related]
6. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. Gil-Núñez AC; Villanueva JA Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205 [TBL] [Abstract][Full Text] [Related]
7. [History and current status of medical treatment for stroke]. Yagita Y Nihon Rinsho; 2016 Apr; 74(4):560-6. PubMed ID: 27333740 [TBL] [Abstract][Full Text] [Related]
8. A review of therapeutic strategies for risk reduction of recurrent stroke. Phillips RA Prog Cardiovasc Dis; 2008; 50(4):264-73. PubMed ID: 18156005 [TBL] [Abstract][Full Text] [Related]
9. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey]. Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291 [TBL] [Abstract][Full Text] [Related]
10. Secondary prevention of stroke: a practical guide to drug treatment. Koennecke HC CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapy of stroke]. Bereczki D Neuropsychopharmacol Hung; 2009 Mar; 11(1):7-13. PubMed ID: 19731813 [TBL] [Abstract][Full Text] [Related]
12. Multimodal effects of available drugs for ischemic stroke. Chen M; Selim M Drugs Today (Barc); 2005 Jun; 41(6):401-9. PubMed ID: 16110347 [TBL] [Abstract][Full Text] [Related]
16. Optimizing vascular risk reduction in the stroke patient with atherothrombotic disease. Ovbiagele B Med Princ Pract; 2010; 19(1):1-12. PubMed ID: 19996612 [TBL] [Abstract][Full Text] [Related]
17. Acute Care of Ischemic Stroke Patients in the Hospital. Meisel KM; Thabet AM; Josephson SA Semin Neurol; 2015 Dec; 35(6):629-37. PubMed ID: 26595863 [TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B; Martínez-Sánchez P; Díez-Tejedor E Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [TBL] [Abstract][Full Text] [Related]
19. Long-term therapy to prevent stroke. Kirshner HS; Biller J; Callahan AS J Am Board Fam Pract; 2005; 18(6):528-40. PubMed ID: 16322415 [TBL] [Abstract][Full Text] [Related]
20. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy? Johnson P; Rosewell M; James MA Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]